The protein FAAP, or Fanconi Anemia Associated Protein, plays a critical role in the maintenance of genomic integrity through its involvement in the DNA repair process, particularly in the Fanconi anemia (FA) pathway. This pathway is essential for the repair of interstrand cross-links (ICLs) in DNA, which if left unaddressed, can lead to genomic instability, cell cycle arrest, and cell death. FAAP is integral to the FA core complex, a multiprotein assembly that recognizes ICL damage and initiates repair by recruiting and activating downstream repair proteins. The functional significance of FAAP within this complex underscores its role in orchestrating a coordinated response to DNA damage, thereby safeguarding the cell against genetic alterations that could lead to malignancies.
Activation of FAAP and the FA pathway occurs through a tightly regulated process that begins with the detection of DNA damage. Upon encountering ICLs, the FA core complex, inclusive of FAAP, is recruited to the damage site. This recruitment is mediated by interactions with other DNA repair proteins and modifications of DNA and histones, highlighting the complex network of signaling required for activation. Post-translational modifications, particularly mono-ubiquitination of FANCD2 and FANCI, are key events in the activation of the FA pathway. These modifications enhance the affinity of the FA core complex for DNA, facilitating its function in ICL repair. Additionally, the interaction of FAAP with other proteins in the FA pathway is modulated by phosphorylation and other post-translational modifications, which further regulate the activity and stability of the FA complex. Through these mechanisms, FAAP plays a pivotal role in activating the FA pathway, ensuring a robust and precise response to DNA damage. This activation not only enables the repair of ICLs but also integrates with other DNA repair mechanisms, contributing to the overall maintenance of genomic stability and the prevention of disease processes associated with DNA damage accumulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a direct activator of adenylyl cyclase, leading to increased cAMP levels. FAAP is known to be involved in the cAMP signaling pathway, and the increase in cAMP can lead to functional activation of FAAP. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine is an atypical antipsychotic that can activate G-protein-coupled receptors (GPCRs). FAAP is involved in GPCR signaling, so the activation of these receptors by Clozapine can enhance the function of FAAP. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that may enhance the functional activity of FAAP. Glucocorticoids can increase the activity of the PI3K/AKT pathway which FAAP is known to regulate. Through elevating the PI3K/AKT pathway, Dexamethasone enhances FAAP activity, leading to increased protein functionality. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is a hormone and neurotransmitter that activates adrenergic receptors, which are GPCRs. As FAAP is involved in GPCR signaling, the activation of these receptors can enhance the function of FAAP. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can influence the PI3K/AKT/mTOR pathway, which FAAP is known to regulate. This can enhance the functional activity of FAAP. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to activation of the PI3K/Akt pathway. As FAAP is involved in this pathway, insulin can enhance the function of FAAP. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors. These receptors are coupled to G-proteins and can trigger intracellular signaling cascades that FAAP is involved in, leading to its functional activation. | ||||||